Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by Gilliland Jeter Wealth Management LLC

Gilliland Jeter Wealth Management LLC lessened its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 0.8% during the fourth quarter, Holdings Channel reports. The fund owned 12,723 shares of the company’s stock after selling 100 shares during the quarter. Gilliland Jeter Wealth Management LLC’s holdings in Inspire Medical Systems were worth $2,359,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. True Wealth Design LLC acquired a new stake in shares of Inspire Medical Systems in the 3rd quarter worth about $30,000. Farther Finance Advisors LLC increased its holdings in shares of Inspire Medical Systems by 1,158.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after acquiring an additional 139 shares during the period. GAMMA Investing LLC increased its holdings in shares of Inspire Medical Systems by 559.3% in the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after acquiring an additional 151 shares during the period. Signaturefd LLC grew its position in Inspire Medical Systems by 45.9% in the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock valued at $57,000 after buying an additional 85 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Inspire Medical Systems by 37.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock valued at $68,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 5.7 %

INSP stock opened at $181.14 on Friday. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The firm has a market capitalization of $5.43 billion, a PE ratio of 169.29 and a beta of 1.32. The firm has a 50-day moving average of $190.19 and a two-hundred day moving average of $189.74.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.29) earnings per share. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 1.35 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on INSP shares. Wells Fargo & Company increased their target price on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Robert W. Baird raised their price objective on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research report on Tuesday, November 5th. KeyCorp restated an “overweight” rating and set a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Stifel Nicolaus reduced their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $260.00 price objective on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.